NASDAQ: PMN
Promis Neurosciences Inc Stock Ownership - Who owns Promis Neurosciences?

Insider buying vs selling

Have Promis Neurosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Max A. MilburyInsider2025-10-0330,392$0.49
$14.92kBuy
Neil CashmanChief Scientific Officer2025-02-1015,000$0.97
$14.60kBuy

1 of 1

PMN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PMN insiders and whales buy or sell their stock.

PMN Shareholders

What type of owners hold Promis Neurosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jeremy M. Sclar336.65%7,246,296$67.68MInsider
Ally Bridge Group Ny LLC289.60%6,233,497$58.22MInstitution
Abg Management Ltd281.48%6,058,738$56.59MInsider
Slanix Paul Alex281.48%6,058,738$56.59MInsider
Shaf Qic LLC240.88%5,184,760$48.43MInsider
Armistice Capital LLC138.19%2,974,518$27.78MInstitution
Michael S. Gordon115.37%2,483,362$23.19MInsider
19 Promis Title113.13%2,435,029$22.74MInsider
M. Sclar 2012 Irrevocable Family Trust Jeremy75.14%1,617,437$15.11MInsider
Sphera Funds Management Ltd13.71%295,187$2.76MInstitution

1 of 3

PMN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMN23.87%76.13%Net BuyingNet Buying
VYNE12.04%78.86%Net SellingNet Selling
QCLS0.23%99.77%
GDTC0.16%57.45%
ENLV3.72%59.15%

Promis Neurosciences Stock Ownership FAQ

Who owns Promis Neurosciences?

Promis Neurosciences (NASDAQ: PMN) is owned by 464.30% institutional shareholders, 1,481.21% Promis Neurosciences insiders, and 0.00% retail investors. Jeremy M. Sclar is the largest individual Promis Neurosciences shareholder, owning 7.25M shares representing 336.65% of the company. Jeremy M. Sclar's Promis Neurosciences shares are currently valued at $64.64M.

If you're new to stock investing, here's how to buy Promis Neurosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.